CBN (cannabinol): what it is, effects, sleep and CBN vs CBD
By the Golden High teamUpdated 27 October 202610 min read
Minor cannabinoids
CBN, or cannabinol, is the cannabinoid that forms as THC ages: air, light and heat oxidise it and slowly turn it into CBN. It has a reputation as the "sleep cannabinoid", but human studies are rare, small and their results mixed. Here's what it really is, where that reputation comes from, what research says, how it differs from CBD and CBG, and where the legal question stands in Italy.
Double Peach Delta-P 30%
A resin with a fruity, sweet profile and a mid-range percentage, for those who already know Delta-P.
From7,90 €View product →
Heisenberg Delta-P 60%
A bluish Piatella look, blueberry notes and the highest percentage among our resins. For connoisseurs only.
From7,90 €View product →The definition
What is CBN: the cannabinoid born from THC.
CBN is one of the more than 150 phytocannabinoids described in cannabis. Yet it has one feature that sets it apart from almost all the others: the plant doesn't make it directly. The main cannabinoids come from the same "mother" molecule, cannabigerolic acid (CBGA), converted by specific enzymes. For CBN, no biosynthetic pathway has been identified.
In practice, CBN is a breakdown product of THC. Over time, in contact with oxygen, part of the THC molecule "aromatises" and becomes cannabinol. The older and more poorly stored a herb or resin is, the more CBN it contains. That's why it's called the cannabinoid of time.
- Full name: cannabinol.
- Origin: oxidation of THC, mainly in aged cannabis.
- Receptors: it acts on CB1 and CB2 receptors, but with an affinity for CB1 roughly ten times lower than THC's.
- Reputation: the "sleep cannabinoid", an idea research hasn't confirmed yet.
A century of history
The first cannabinoid isolated, and the most misunderstood.
CBN holds a little-known record: it was the first phytocannabinoid ever isolated, at the end of the 19th century, from charas, the hand-harvested Indian resin. But its discovery caused more confusion than clarity. The material reached Europe after months of travel, stored carelessly: meanwhile THC was breaking down and CBN was building up. The first researchers were therefore studying an already "aged" resin, and their observations on its effects were skewed.
1896
Chemists Wood, Spivey and Easterfield publish their work on charas resin.
1899
The same authors publish the study devoted to "cannabinol", a name that moved from a distilled red oil to the pure molecule.
1930s
British chemist Robert Cahn clarifies the structure of the molecule.
1940
American chemist Roger Adams achieves the first total synthesis of CBN and confirms its structure.
CBN is also extremely stable. Cannabis seeds dating from 750 BC, found in a tomb in the Xinjiang region of China, still contained high amounts of it. That's why it's used as a marker to identify cannabis in archaeological remains.
From THC to CBN
Air, light, heat: how THC becomes CBN.
In the fresh plant, THC exists mainly in acid form, THCA, which we covered in our article what is THCA. With drying and heat, THCA loses a carboxyl group and becomes THC. Then, over the months, oxygen does the rest.
THC → CBN
The main route. Exposed to air, THC slowly oxidises: its ring aromatises and the molecule becomes cannabinol. Light and heat speed the process up.
THCA → CBNA
Some hemp samples contain small amounts of cannabinolic acid (CBNA), a sign that the same oxidation can, under certain conditions, happen even before THCA becomes THC.
The practical consequence: a product's CBN level says a lot about its age and storage. It's also why extracting CBN from the plant gives low, irregular yields, and why chemists have developed several synthesis routes to study it in the lab.
The same principle applies to all your products: a well-sealed jar, away from light and kept cool, preserves aromas and composition better than a bag left open in the sun.
What the sources say
CBN effects: what we really know.
CBN is often described as "mildly psychoactive". The reason is chemical: it acts on the same receptors as THC, but much more weakly. To understand how these receptors work, we wrote a dedicated guide: CB1 and CB2, the receptors that drive your experience. Here are the most solid references on CBN.
Pharmacology · 2022 review
CBN is an agonist of CB1 and CB2 receptors, but its affinity for CB1, the one linked to psychoactive effects, is roughly ten times lower than THC's. It's also less effective than THC at activating it.
Small human study · five volunteers
Five men received oral CBN (50 mg), THC (12.5 mg) or combinations of the two. The authors of the 2022 review report increased sedation when CBN and THC were combined, with a modest rise in reported drowsiness and dizziness.
Narrative review · 2026
A review of the clinical literature up to March 2026 concludes that the evidence on CBN remains minimal and insufficient to support any clinical recommendation.
In other words: CBN isn't a "THC light" to dose at will, nor a molecule whose effects are well known. We know it acts on the endocannabinoid system, but to what extent, how and at what doses remains poorly documented. References at the bottom of the page.
The question everyone asks
CBN and sleep: the reputation and the data.
Where does the "sleep cannabinoid" reputation come from? The reasons remain hazy. The most cited hypothesis: old cannabis, rich in CBN, supposedly gives a heavier feeling. Marketing did the rest, with the slogan of the "sleepy cannabinoid from old weed". Over the years, animal studies have produced contradictory results. The first human trials only arrived recently.
| 2024 trial (United States) | 2026 trial (Australia) | |
|---|---|---|
| Participants | Adults aged 18 to 55 with "poor" sleep, 293 analysed | 20 adults with diagnosed insomnia |
| Doses | 20 mg of CBN, alone or with CBD, for 7 nights | 30 mg or 300 mg of CBN, a single night |
| Main result | Sleep quality: no significant difference versus placebo | Night-time wakefulness: no significant change |
| Other results | Fewer night-time awakenings with 20 mg; adding CBD didn't strengthen the effect | A few measures improved at 300 mg only; 247 mild to moderate adverse events across all groups |
Two studies, one of them on twenty people over a single night, aren't enough to establish an effect. The Australian authors themselves conclude that larger, longer trials are needed. And the 2022 review sums it up: from a clinical point of view, the idea that CBN promotes sleep has not been demonstrated.
Key point: CBN isn't a medicine and no CBN product can promise you'll sleep. If you have sleep problems, talk to a doctor. And never combine cannabinoids with alcohol or sleeping pills.
Comparison
CBN vs CBD: three acronyms, three origins.
People often mix them up because they have three letters and the same initial. But CBN, CBD and CBG don't form the same way and don't hold the same place in the plant.
| CBN | CBD | CBG | |
|---|---|---|---|
| How it forms | From oxidation of THC, no known biosynthetic pathway | Made by the plant from CBGA (via CBDA) | Neutral form of CBGA, the "mother" molecule |
| When it's most abundant | In old or poorly stored cannabis | In the plant, from harvest | In the plant, as the precursor of the others |
| Category | "Minor" cannabinoid | One of the four main ones | One of the four main ones |
| Human research | A few small recent trials | The most studied: CBD-based medicines are registered | Far less studied than CBD |
The most important difference between CBN and CBD: CBN derives from THC and keeps a weak affinity for the CB1 receptor, whereas CBD follows a different route from the plant onwards. If lesser-known cannabinoids interest you, also read our article on CBC, the cannabinoid in the shadows.
And in Italy?
CBN and the law: a framework on the move.
In Italy, the legal question turns less on the molecule itself than on the material it comes from. Since 2025, the so-called "security" decree has changed the rules on hemp, and its application is now being challenged in the courts. Here are the key dates, checked on 19 October 2026.
12 April 2025
Decree-law no. 48/2025 comes into force. Its article 18 amends law 242/2016: it bans the import, supply, processing, distribution, trade, transport and delivery of hemp inflorescences and products containing them, including the extracts, resins and oils derived from them.
9 June 2025
The decree is converted into law no. 80/2025, published in the Italian Official Gazette the same day.
2 December 2025
The court of Brindisi raises a constitutional question on article 18 (order published in the Official Gazette on 25 February 2026).
28 April 2026
The court of Trani in turn refers article 18 to the Constitutional Court.
9 February 2027
Date of the public hearing set by the Constitutional Court. Until a ruling, the rule stays in force.
And in France, where our parcels ship from? In 2024 the ANSM (the French medicines agency) classified cannabinoids with a benzo[c]chromene core as controlled drugs, but expressly excluded CBN. Being left off a list doesn't mean, however, that any CBN product is authorised.
Good to know: we don't claim that a CBN product is legal in Italy. The framework depends on the product's origin and on the rulings expected from the Constitutional Court. If in doubt, check before you buy.
At our place
What you'll find at Golden High.
We don't sell CBN products. Our Delta-P range is CBDX-based, under 0.3% THC, lab-tested, with the percentage shown on every product. These are Delta-P versions of a style, not THC products. All the details are in the complete Delta-P guide.
If you like fruity resins, the Double Peach Delta-P 30% is a good starting point. For connoisseurs, the Heisenberg Delta-P 60% is our highest percentage. And for flowers, browse the Delta-P flowers collection.
Check the percentage
A serious product lists its cannabinoids and stays under 0.3% THC.
Ask for the lab test
Every batch should be traceable to a certificate of analysis from a third-party lab.
Start low
A moderate percentage, a small amount and time between doses. Adults only, never before driving.
Your questions
What people ask us about CBN.
What is CBN?
CBN, or cannabinol, is a cannabinoid that forms as THC oxidises over time, in contact with air, light and heat. So there's more of it in old or poorly stored cannabis.
Does CBN get you high?
CBN is considered mildly psychoactive: it acts on the CB1 receptor like THC, but with an affinity roughly ten times lower. Human data is rare, so its effects at a given dose remain hard to predict. Never before driving.
Does CBN help you sleep?
It hasn't been demonstrated. A 2024 trial observed fewer night-time awakenings with 20 mg of CBN, but no significant difference in sleep quality. A 2026 trial on 20 people with insomnia found no effect on its main outcome.
What's the difference between CBN and CBD?
CBD is made directly by the plant and is among the most studied cannabinoids. CBN derives from the oxidation of THC, keeps a weak affinity for the CB1 receptor, and has been far less studied.
Are CBN and CBG the same thing?
No. CBG derives from CBGA, the "mother" molecule the plant uses to produce the other acidic cannabinoids. CBN has no known biosynthetic pathway: it forms from the breakdown of THC.
Is CBN legal in Italy?
There's no simple answer. Since 2025, article 18 of the "security" decree bans trade in hemp inflorescences and their extracts, and this rule is under review by the Constitutional Court, with a hearing set for 9 February 2027.
Does Golden High sell CBN products?
No. Our Delta-P range is CBDX-based, under 0.3% THC, lab-tested and with the percentage shown on every product. You'll find the details on our Delta-P page.
Sources
The references cited in this article.
- Maioli C. et al., Plants (2022). Cannabinol: History, Syntheses, and Biological Profile of the Greatest "Minor" Cannabinoid.
- Bonn-Miller M.O. et al., Experimental and Clinical Psychopharmacology (2024). A double-blind, randomized, placebo-controlled study of the safety and effects of CBN with and without CBD on sleep quality.
- Lavender I.G. et al., Journal of Sleep Research (2026). Cannabinol for Acute Treatment of Insomnia Disorder in a Randomized Placebo-Controlled Crossover Trial.
- Kishi Y. et al., PCN Reports (2026). Psychiatric effects of cannabidiol, cannabinol, and tetrahydrocannabinol: A narrative review of clinical evidence and risk profiles.
- Gazzetta Ufficiale (2026). Order no. 26 of 2 December 2025 (court of Brindisi) on art. 18 of decree-law no. 48 of 11 April 2025 (in Italian).
- Corte costituzionale (2026). Record of order no. 81 of 2026 (court of Trani) (in Italian).
- ANSM (2024). L'ANSM inscrit de nouveaux cannabinoïdes sur la liste des stupéfiants (in French).
